[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369870-105":59,"doc-detail-369870-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","germline-cdkn2a-variant-cascade-testing-across-four-generations-reveals-familial-melanoma-breast-cancer-genotype-phenotype-correlation","Germline CDKN2A Variant Cascade Testing Across Four Generations Reveals Familial Melanoma - Breast Cancer Genotype - Phenotype Correlation","","Study reports co-segregation of a pathogenic CDKN2A germline variant with both melanoma and breast cancer across a four-generation pedigree. Eighteen individuals were classified as test positive, obligate, or assumed carriers, and 11 carriers developed multiple melanomas with initial diagnoses spanning teens to fifties. Among female carriers, 6 had breast cancer with diagnoses spanning thirties to sixties. Additional malignancies included pancreatic and head and neck cancers. Results support a possible genotype–phenotype association between the CDKN2A variant and hereditary co-occurrence of melanoma and breast cancer, contextualized with background prevalence and known cancer predisposition risks.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/germline-cdkn2a-variant-cascade-testing-across-four-generations-reveals-familial-melanoma-breast-cancer-genotype-phenotype-correlation/369870/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/germline-cdkn2a-variant-cascade-testing-across-four-generations-reveals-familial-melanoma-breast-cancer-genotype-phenotype-correlation/369870.png","ImageObject",300,407,{"name":92,"@type":93},"Aldword","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main genetic finding in this four-generation family?","Question",{"text":112,"@type":113},"A pathogenic CDKN2A germline variant co-segregates with both melanoma and breast cancer across the pedigree.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many individuals were identified as carriers of the CDKN2A variant?",{"text":117,"@type":113},"Eighteen individuals were test positive (n = 10), obligate (n = 5), or assumed carriers (n = 3).",{"name":119,"@type":110,"acceptedAnswer":120},"What additional cancers were reported beyond melanoma and breast cancer?",{"text":121,"@type":113},"Pancreatic cancer and head and neck cancers were also reported among the additional cancer diagnoses.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369870,1791394085,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","The official journal of  \nINTERNATIONAL FEDERATION OF PIGMENT CELL SOCIETIES · SOCIETY FOR MELANOMA RESEARCH  \nPIGMENT CELL & MELANOMA Research  \nGermline CDKN2A Variant Cascade Testing Across Four Generations Reveals Familial Melanoma–Breast Cancer Genotype– Phenotype Correlation   \nJennifer Berkman1,2 | Ellie J. Maas1  | E. DeBortoli1 | Clare A. Primiero1,2 | H. Peter Soyer1,2  | Aideen McInerneyLeo1  \nDOI: 10.1111/pcmr.70055  \nIf you wish to order reprints of this article, please see the guidelines here  \nEMAIL ALERTS  \nReceive free email alerts and stay up-to-date on what is published in Pigment Cell & Melanoma Research – click here  \nSubmit your next paper to PCMR online at [https://submission.wiley.com/journal/pcmr](https://submission.wiley.com/journal/pcmr)  \nSubscribe to PCMR and stay up-to-date with the only journal committed to publishing basic research in melanoma and pigment cell biology  \nAs a member of the IFPCS or the SMR you automatically get online access to PCMR. Sign up asa member today at www.ifpcs.org or [at](at www.societymelanomaresearch.org/)[ www.societymelanomaresearch.org/](at www.societymelanomaresearch.org/)  \nTo take out a personal subscription, please click here  \nPigment Cell & Melanoma Research   \n SHORT COMMUNICATION  OPEN ACCESS   \nGermline CDKN2A Variant Cascade Testing Across Four Generations Reveals Familial Melanoma–Breast Cancer Genotype–Phenotype Correlation  \nJennifer Berkman1,2 | Ellie J. Maas1  | E. DeBortoli1 | Clare A. Primiero1,2 | H. Peter Soyer1,2  | Aideen McInerney-Leo1  \n1Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia | 2Department of Dermatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia  \nCorrespondence: Aideen McInerney-Leo ([a.mcinerney@uq.edu.au](a.mcinerney@uq.edu.au))  \nReceived: 31 March 2025 | Revised: 27 August 2025 | Accepted: 9 September 2025  \nFunding: H.P.S. holds an NHMRC MRFF Next Generation Clinical Researchers Program Practitioner Fellowship (APP1137127) . A.M.-L. is currently supported by a University of Queensland Faculty of Medicine Fellowship. This work was also made possible by a Metro South Health Research Support Scheme Program Grant (RSS_2021_ 028). Funding for whole-exome sequencing was provided by Queensland Genomics, Queensland Government, Round 1 Demonstration Project grant. This research was carried out at the Translational Research Institute (TRI), Woolloongabba, Queensland, Australia.  \nKeywords: breast cancer | CDKN2A | familial | germline | melanoma  \nABSTRACT  \nThis study reports co-segregation of a pathogenic CDKN2A variant with both melanoma and breast cancer in a four-generation pedigree. Eighteen individuals were test positive (n = 10), obligate (n = 5) or assumed carriers (n = 3) of the CDKN2A variant. Eleven of these had multiple melanomas, with initial diagnoses from teens to fifties. Six of thirteen female carriers had breast cancer (n = 5 test positive, n = 1 assumed carrier), with diagnoses ranging from thirties to sixties. Additional cancer diagnoses included pancreatic, and head and neck cancers. This study illustrates a possible genotype–phenotype association between a pathogenic CDKN2A variant and the co-occurrence of melanoma and breast cancer in a hereditary context.  \nBreast cancer and primary melanoma are the second and third most common cancers in Australia, respectively, accounting for 28% and 11% of all cancer diagnoses each year (Australian Institute of Health and Welfare 2024). The most frequently implicated predisposition genes are BRCA1 and BRCA2 for breast cancer (Kuchenbaecker et al. 2017) and CDKN2A for familial melanoma (Cust et al. 2011) . A variant in a predisposition gene significantly increases the cumulative risk of developing these cancers by 80 years of age, with an estimated lifetime risk of 69%–72% for BRCA1/BRCA2 mutation-positive breast cancer (Kuchenbaecker et al. 2017), and 52% for CDKN2A mutationpositive melanoma (Cust","cbCaitsDCMsTd2ZW","https://ap.wps.com/l/cbCaitsDCMsTd2ZW","pdf",883238,"English","# ABSTRACT\n## Four-generation co-segregation findings\n## Female carrier outcomes and additional cancers\n## Broader genotype–phenotype context and known risk evidence\n## Summary bullet points","[{\"question\":\"What is the main genetic finding in this four-generation family?\",\"answer\":\"A pathogenic CDKN2A germline variant co-segregates with both melanoma and breast cancer across the pedigree.\"},{\"question\":\"How many individuals were identified as carriers of the CDKN2A variant?\",\"answer\":\"Eighteen individuals were test positive (n = 10), obligate (n = 5), or assumed carriers (n = 3).\"},{\"question\":\"What additional cancers were reported beyond melanoma and breast cancer?\",\"answer\":\"Pancreatic cancer and head and neck cancers were also reported among the additional cancer diagnoses.\"}]","Germline CDKN2A Variant Cascade Testing Across Four Generations Reveals Familial Melanoma - Breast Cancer Genotype - Phenotype Correlation | PDF",1790184982,15,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7627bddeff721d764720cd2f227ba5c8.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37753d0e6a0f726fe3b36b5ca119515e.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e492453cde98998c39b5186217350d3.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/607b238684f4e8bf2469167f5e305f30.webp",980,1287]